Artemis Therapeutics Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 14, 2019 at 12:54 pm EST
Artemis Therapeutics Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating income was USD 22,000 compared to USD 203,000 a year ago. Net loss was USD 24,000 compared to USD 108,000 a year ago. Basic eps was USD 0 compared to basic loss per share of USD 0.02 a year ago. For the nine months, operating income was USD 112,000 compared to USD 715,000 a year ago. Net loss was USD 114,000 compared to USD 460,000 a year ago. Basic loss per share was USD 0.02 compared to USD 0.08 a year ago.